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Beyond the rhetorical call for increasing patients’ engagement, policy makers recognize
the urgency to have an evidence-basedmeasure of patients’ engagement and capture its
effect when planning and implementing initiatives aimed at sustaining the engagement of
consumers in their health. In this paper, authors describe the Patient Health Engagement
Scale (PHE-scale), a measure of patient engagement that is grounded in rigorous
conceptualization and appropriate psychometric methods. The scale was developed
based on our previous conceptualization of patient engagement (the PHE-model). In
particular, the items of the PHE-scale were developed based on the findings from the
literature review and from interviews with chronic patients. Initial psychometric analysis
was performed to pilot test a preliminary version of the items. The items were then
refined and administered to a national sample of chronic patients (N = 382) to assess
the measure’s psychometric performance. A final phase of test-retest reliability was
performed. The analysis showed that the PHE Scale has good psychometric properties
with good correlation with concurrent measures and solid reliability. Having a valid and
reliable measure to assess patient engagement is the first step in understanding patient
engagement and its role in health care quality, outcomes, and cost containment. The
PHE Scale shows a promising clinical relevance, indicating that it can be used to tailor
intervention and assess changes after patient engagement interventions.
Keywords: patient engagement, patient activation, patient engagement measurement, patient health engagement
scale, psychometric properties, ordinal scale
Introduction
In the last decades, the increased epidemiology of chronic conditions, due to the aging of the pop-
ulation and to the diffusion of environmental stressors, has implied an enhanced organizational
and economic effort of the healthcare system (Lassman et al., 2014; Pallin et al., 2014). This effort
implies a burden difficult to be dealt, also due to the general reduction of resources that the health-
care organizations have to face in the present period of economic crisis. In other words, healthcare
organizations today have to “do more with less” (Steinmann et al., 2007; Hartholt et al., 2011). In
this scenario, healthcare experts, managers, and policy makers are recognizing the importance of a
paradigm shift in the planning and delivery of healthcare in the favor of promoting a more active
role of patients in the management of their healthcare (Barello et al., 2014a; Menichetti et al., 2014).
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In the field of medicine and public health management, recent
theorizations have indeed advocated considering patients as
important human resources that should be actively involved in
the healthcare organization and along the process of care delivery
(Crawford et al., 2002; Davis et al., 2005; Clancy, 2011; Bellardita
et al., 2012; Graffigna et al., 2013a; Barello et al., 2014b, 2015a).
There is a shared agreement that making patients better informed
and more directly responsible for their health and care man-
agement is pivotal to make healthcare organizations better sus-
tainable at the economic, organizational, and psychological level
(Coulter et al., 2012; Graffigna et al., 2014). To engage patients
in healthcare is considered across the world as a key strategy
to improve patients’ adherence, clinical outcomes, and satis-
factions toward the received care. (Renedo and Marston, 2011;
Coulter, 2012a,b; Ocloo and Fulop, 2012; Barello and Graffigna,
2014). Furthermore, the achievement of a concrete engagement
of patients in their healthcare management has also been envis-
aged as an effective strategy to reduce healthcare costs (Burns
et al., 2014; Provenzi et al., 2015).
However, current practices devoted to improve patient
engagement in their healthcare management show a lack of
shared guidelines to achieve this goal (Hor et al., 2013; Hardy-
man et al., 2015). Furthermore, experts testify a certain confusion
about what patient engagement is and how it may be conceptu-
alized and achieved, as testified by the plethora of terms often
used as interchangeable in this domain (Graffigna et al., 2013a,
2015; Menichetti et al., 2014). Finally, only few empirical studies
aimed to measure healthcare performances and their ability to
improve the engagement of patients, with results that are poorly
comparable and generalizable (Staniszewska et al., 2008). This
is also due to the lack of instruments able to assess the level
of patient engagement in healthcare management. Particularly,
this lack of concrete instruments to assess patient engagement
is potentially detrimental to the broadly accepted assumption
that health care practices need to be align with evidence-
based insights about individuals’ healthcare preferences and
needs.
FIGURE 1 | The patient health engagement model, adapted from Graffigna et al. (2013b).
So far, in the international scenario, only one assessment
instrument in this conceptual area exists, the Patient Activation
Measure (PAM). The PAM, developed by Hibbard et al. (2004,
2005), is a powerful instrument able to detect the level of acti-
vation of patients toward their care management (Hibbard and
Mahoney, 2010; Greene and Hibbard, 2012). This scale has been
widely used in the US to orient medical practices, and it has now
been validated in several countries (Maindal et al., 2009; Brenk-
Franz et al., 2013; Ahn et al., 2014; Magnezi and Glasser, 2014;
Graffigna et al., under review). However, although the concepts
of “activation” and “engagement” have some areas of conceptual
overlapping, they differ according to the breath of the healthcare
relation considered. The concept of “activation” is mainly lim-
ited to the prototypical situation of a doctor-patient consultation
while the concept of “engagement” seeks to consider multiple lev-
els of the patients’ fruition of the healthcare (Menichetti et al.,
2014). Furthermore, the concept of activation is related mainly
to the cognitive and behavioral components of patients’ attitude
toward healthcare, and it is mainly conceptualized as an incre-
mental attitude that the patientmay develop. On the contrary, the
concept of engagement offers a more holistic consideration of the
psychological elaboration of the patient about his/her health con-
dition and presents a multi-stage development (Graffigna et al.,
2014). Precisely, patient engagement is a “process-like and multi-
dimensional experience, resulting from the conjoint cognitive
(think), emotional (feel), and conative (act) enactment of individ-
uals toward their health management. In this process, patients go
through four subsequent positions (i.e., blackout, arousal, adhe-
sion, and eudaimonic project; see Figure 1). The unachieved syn-
ergy among the different subjective dimensions (think, feel, act)
at each stage of the process may inhibit patients’ ability to engage
in their care” (Graffigna et al., 2014, p. 1). Precisely, in previ-
ous studies, we developed the Patient Health Engagement (PHE)
model based on evidence about patients’ experiences and pref-
erences regarding their engagement in care management, which
may be considered as a compass to help healthcare practition-
ers and policy makers customize their interventions to engage
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patients in care management (Graffigna et al., 2014). According
to the PHE model’s process view of patient engagement, individ-
uals may be differentially engaged in care management accord-
ing to their emotional, cognitive, and behavioral mindset. For
instance, when a patient receives a serious diagnosis, s/he might
not be able to engage fully in care management because of desta-
bilizing emotional effect on health knowledge (blackout posi-
tion). The healthcare system at this stage needs to provide a more
systematic assistance and scaffolding that would include the care-
givers’ main needs and priorities. Across the patient’s engagement
journey, on the contrary, as patients gain knowledge, they gener-
ally becomemore emotionally stabilized and thus more confident
in their ability to engage in managing their disease condition (i.e.,
positions of arousal, adhesion, eudaimonic project).
According to the PHE model, we argue that practitioners
and healthcare services that are better attuned to the engage-
ment stage of patients may develop a more effective flexibility
in their strategies to promote the active role of patients in their
care management. Clearly, there is no monolithic engagement
trajectory for all patients. However, an important precursor to
improving healthcare is to undertake an engagement-sensitive
approach based on the patients’ desires and expectations. Fail-
ure to recognize and support the patients’ engagement status
might result in misalignment patient-provider expectations, dis-
satisfaction with care, and poor adherence to treatments, which
undermine the real translation of the patient engagement goal
into practice.
Based on this framework, patients’ activation may be con-
sidered a precursor of patients’ engagement, but it does not
coincide with the phenomenon of engagement (Graffigna et al.,
2015; Menichetti et al., 2014). Furthermore, due to the com-
plex and dynamic psychological nature of the patient engagement
experience, specific assessment tools are needed that are able to
grasp the multifaceted nature of the emotional and motivational
experience of patients during their healthcare management
journey.
Based on these premises, the present paper describes the psy-
chometric proprieties of a new scale developed based on the PHE
model (the PHE-scale). In particular, the aim of the present study
is three-fold: (1) to evaluate the psychometric properties of the
PHE-scale and (2) to evaluate the association between PHE-scale
scores and concurrent measures.
Materials and Methods
Development of the PHE-Scale
The items and the structure of the scale were developed based
on a systematic analysis of the literature (Barello et al., 2014a,b)
and an extensive qualitative study aimed at deeply exploring
chronic patients’ journey about their care management (Barello
et al., 2014b; Graffigna et al., 2014, under review). The scale
thus presents a bottom up development and is particularly able
to grasp inner psychological experiences of patients along their
engagement stages.
The scale adopted an ordinal structure in order to be con-
sistent with the PHE model’s conceptualization, which envisages
four different positions along the engagement continuum. Items
were formulated based on the interviewees’ spontaneous narra-
tives in order to describe the subjective positions that a patient
may experience along his/her engagement journey. Although the
PHE model described four engagement positions, the ordinal
scale was measured on a 7-point scale (see Supplementary Mate-
rial) in order to facilitate patients’ responses and to avoid social
desirability bias (Furnham, 1986). For example, to declare a low
position of engagement (e.g., the blackout) might be considered
poorly socially acceptable by respondents, and it might thus be
avoided. On the contrary, the possibility to rate one-self in an
intermediate position (e.g., between the blackout and the arousal)
may facilitate an accurate self-description. For these reasons, in
the following analyses, we coded intermediate positions between
the four stages as equivalent to the previous engagement position,
i.e., a score of 2 on the 7 points scale means that respondent posi-
tions him/herself in the first stage of engagement while a rate 6
means a position in the third stage.
The PHE-scale originally consisted of 9 ordinal items, and it
was reduced to 5 ordinal items after the first pilot phase (see
following paragraphs). The 5 final items are presented in the Sup-
plementary Material, both in the original (Italian) formulation
and in their English translation. The PHE-scale was included in
a longer questionnaire that included concurrent measures (PAM-
13 andMMAS-4) and ad hoc items related to socio-demographics
and clinical descriptive variables.
Concurrent Measures
Patient Activation Measure
Developed by Hibbard et al. (2005), the 13-item Patient Acti-
vation Measure (PAM) is an interval-level, unidimensional
Guttman-like measure that contains items measuring self-
assessed knowledge about chronic conditions, beliefs about ill-
ness and medical care, and self-efficacy for self-care. The PAM
focused on physical conditions, and it was designed to measure
activation as a broad construct. In the present study, we used
the Italian validated version of the PAM (Graffigna et al., under
review).
Morisky Medication Adherence Scale
Medication-taking behavior was assessed using the 4-item
Morisky Medication Adherence Scale (MMAS-4) (Morisky et al.,
1986, 2008; Shalansky et al., 2004). This simple 4-question sur-
vey assesses the likelihood of patients taking their drug therapy
as prescribed. The items measure the degree to which patients
self-report non-adherence with prescribedmedication due to for-
getting, carelessness, stopping the drug when feeling better or
stopping the drug when feeling worse. In the present study, we
used the Italian validated version of the MMAS-4 (Fabbrini et al.,
2013).
Demographic and Clinical Variables
A set of ad hoc items were included in the questionnaire in order
to describe socio-demographic and clinical characteristics of the
patients. Those also served as screening variables in order to
select panel respondents. These items were related particularly
to the following patients’ characteristics: age; gender; education;
marital status; type of diagnosis; year from the first diagnosis.
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Procedure
The data were collected from a panel of chronic patients. To be
included in the panel, patients had to be: (1) Italian and reside
in Italy; (2) diagnosed with one or more chronic diseases; (3) not
diagnosed with a major psychiatric disturbance; (4) following a
chronic treatment for their disease/s; (5) aged>18 years old; and
(6) of both genders.
The data collection was performed in three phases through
the QUALTRICS online system. The first pilot phase was con-
ducted on a sample of 48 chronic patients using the long version
of the PHE-scale (9 ordinal items) together with the concurrent
measures and the ad hoc items related to socio-demographic and
clinical variables. After the completion of the questionnaire, in
the pilot phase, patients were also required to discuss the read-
ability of the instrument and to indicate potential problems with
answering the scale items. This preliminary assessment allowed
us to select 5 items. A new data collection wave based on the
revised version of the questionnaire was then conducted on a
sample of 352 chronic patients. In addition, the final version of
the PHE-scale underwent a final test-re-test data collection phase
on a sub-sample of 30 chronic patients.
Ethical Concerns
The study received approval from the Università Cattolica del
Sacro Cuore Ethics Committee. Patients consented to participate
in the study, and they were allowed to withdraw from the study
whenever they wanted. The data were collected anonymously and
analyzed in an aggregated way.
Results
Participants
Overall, 510 patients were invited to participate in the study but
only 430 met the inclusion criteria and completely answered the
questionnaire for the psychometric analysis. Demographic and
clinical characteristics are summarized in Table 1.
Pilot Study
A preliminary pilot study was conducted in order to calibrate
the PHE scale and to eliminate unnecessary items. Moreover,
upon the completion of the questionnaire, respondents were
also required to discuss the readability of the scale items and to
indicate potential problems in answering. The aim of this first
study was to obtain an ordinal scale comprising a low number of
items measuring the latent construct of interest. The initial scale
comprised 9 ordinal items (Table 2).
The sample of the pilot study comprised 48 subjects (65%
males; 35% females, aged from 21 to 87 years old; M = 58.8
years, SD = 21.1). Since the 9 proposed items had an ordinal
nature, the data analysis involved suitable technique for ordi-
nal data. In particular, the calibration of the scales and the
exploration of the factorial structure were carried out using a
Categorical Principal Component Analysis (CATPCA) and the
reliability analysis was conducted using the Ordinal Alpha via
Empirical Copula Index (Bonanomi et al., 2012, 2014). The lat-
ter is a reliability index for polytomous ordinal items based
on the Spearman grade correlation coefficient, and it considers
TABLE 1 | Demographic and clinical characteristics of the sample.
Demographic variables
Mean age (years) 51.3
Gender (% female) 46.6
MARITAL STATUS (%)
Never married 21.1
Married 68.6
Divorced 8.1
Widowed 2.2
EMPLOYMENT (%)
Employed 43.6
Retired 33
Homemaker 8.3
Student 5.6
Unemployed 6.6
Other 2.9
EDUCATION (%)
None 0.9
Primary school 6
Middle school 12.1
High school 48.4
Graduate or higher 32.6
Clinical variables
DISEASE (%)
Asthma 25.5
Celiac disease 4.8
Hypertension 35.6
COPD 8.1
Type I diabetes 3.7
Type II diabetes 24.2
Cardiovascular disorder 15.3
Cancer 9.6
Chron disease 2.9
Fibromyalgia 7.6
Ulcerous colitis 4.5
Lupus 2.2
Osteoarthritis 10.8
Rheumatoid arthritis 11.1
Myeloid chronic leukemia 0.6
Hypercholesterolemia 22.1
Hepatitis 3.4
Anaemia 9.3
copula-based measures of association across the ordinal vari-
ables. This approach relaxes several restrictive hypotheses that are
present both in the case of classical Cronbach’s Alpha (for met-
ric data) and in the case of Ordinal Alpha proposed by Zumbo
et al. (2007). In this study, an empirical version of the index,
the Ordinal Alpha via Empirical copula, was evaluated; this ver-
sion avoids the researcher to make assumptions about the type of
dependence relating the latent variables underlying the ordinal
indicators.
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TABLE 2 | The 9-item version of the PHE scale.
9-item scale 5-item scale Items
WHEN I THINK ABOUT MY DISEASE
A 1 I feel in blackout I am in alarm I am aware I feel positive
O O O O O O O
B 2 I feel dazed I am in trouble I am conscious I feel serene
O O O O O O O
C – I can’t understand
what happened to
me
I can’t manage the
information that my
physician gives me
The information my
physician gives me is clear
to me
Despite my illness, I know
how to manage my life
O O O O O O O
D – I feel totally
messed up
I am not always able to use
the information my
physician gives me
I understand what my
physician tells me to do
I understood how to
manage my life despite my
illness
O O O O O O O
E – I feel totally in a
maze
I find it hard to gather up the
information my physician
gives me
It is clear to me what my
physician tells me to do
I know everything I should
do to best manage my life
despite my illness
O O O O O O O
F – I let others take
care of me
O I try to manage my disease
but I feel that I am not totally
able
I strictly follow the rules that
my physician gives me
I can autonomously manage
my medical regimen
O O O O O O O
G 3 When I think about
my illness I feel
overwhelmed by
emotions
I feel anxious every time a
new symptom arises
I got used to my illness
condition
Despite my illness I perceive
coherence and continuity in
my life
O O O O O O O
H 4 I am very
discouraged due
to my illness
I feel anxious when I try to
manage my illness
I feel I adjusted to my illness I am generally optimist
about my future and my
health condition
O O O O O O O
I 5 I feel totally
oppressed by my
illness
I am upset when a new
symptom arises
I feel I have accepted my
illness
I can give sense to my life
despite my illness condition
O O O O O O O
Table 3 shows descriptive statistics of all items included in
pilot survey, as well as their Shannon Entropy index. Items with
ceiling effects (medians= 4) were excluded from further analyses
(D–F). Moreover, item C was excluded due to a lower Shannon
Entropy index and because its elimination increased the reliabil-
ity of the scale via an Ordinal Alpha analysis. The final version
of the PHE scale comprised 5 items with promising psychome-
tric properties (considering the sample size and the explorative
nature of the pilot study): ordinal alpha of 0.82 and CATPA
(Table 4) suggested a monodimensional latent structure, with
eigenvalue of 3.69 and 73.84% of explained variance.
In the pilot phase, when requested to assess the question-
naire, patients declared that the items were understandable
and contained familiar wording and descriptions of the patient
engagement that were well attuned to their sentiment.
Validation Study
The validation study was conducted on the final 5-item version
of the scale (see Supplementary Material).
TABLE 3 | Item-level descriptive statistics for ranks on the PHE 9-item
scale.
PHE item Rank Minimum Maximum Median Shannon
range entropy
Item A (1) 1–4 1 4 3 0.81
Item B (2) 1–4 1 4 3 0.81
Item C 1–4 1 4 3 0.77
Item D 1–4 1 4 4 0.76
Item E 1–4 2 4 4 0.74
Item F 1–4 2 4 4 0.74
Item G (3) 1–4 1 4 3 0.90
Item H (4) 1–4 1 4 3 0.90
Item I (5) 1–4 1 4 3 0.95
To test and verify the unidimensionality of the scale, three
analyses were conducted: (a) an exploratory CATPCA, (b) a
confirmatory CFA for ordinal data, and (c) a Rasch Model.
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TABLE 4 | Factor loadings from CATPA—one factor solution—pilot study.
PHE item One factor solution
Item A (1) 0.85
Item B (2) 0.76
Item G (3) 0.91
Item H (4) 0.92
Item I (5) 0.84
TABLE 5 | Item-level descriptive statistics for ranks on the PHE.
PHE item Rank Minimum Maximum Median Shannon
range entropy
Item 1 1–4 1 4 3 0.79
Item 2 1–4 1 4 3 0.85
Item 3 1–4 1 4 3 0.85
Item 4 1–4 1 4 3 0.92
Item 5 1–4 1 4 3 0.88
Furthermore, we assessed the internal consistency and test-
retest reliability.
The validation study involved 382 participants with chronic
disease. The sample was divided into three major subgroups:
Group 1 (n = 206) was used to conduct the exploratory analysis,
Group 2 (n = 146) was used to conduct the confirmatory anal-
ysis. The third group involved 30 subjects to examine test-retest
reliability.
Exploratory Categorical Principal Component
Analysis
Descriptive statistics of the individual items were calculated to
conduct the initial exploration of the data. Table 5 provides the
item-level descriptive statistics for all items. Since the ordinal
nature of the items, the median and the Shannon Entropy Index
were calculated.
Table 6 provides the inter-item polychoric correlation matrix.
The polychoric correlation (Pearson, 1900) is a measure of bivari-
ate association arising when both observed variables are ordered
categorical variables derived from polychotomizing latent under-
lying continuous variables.
The average inter-item polychoric correlation is a subtype
of internal consistency reliability. It is obtained by taking all
of the items on a test that probes the same construct, deter-
mining the polychoric correlation coefficient for each pair of
items and finally taking the average of all of these polychoric
correlation coefficients. Every polychoric correlation coefficient
was higher than 0.5. The average inter-item polychoric cor-
relation is equal to 0.68, which indicates a high correlation
between items.
An exploratory categorical principal component analysis
(CATPCA) was conducted on the final 5-item version of the PHE
scale on Group 1 (n = 206, 54% males and 46% females aged
21–84 years old; M = 52.5 years, SD = 14.9). A CATPCA was
TABLE 6 | Item-item polychoric correlation matrix for ranks on the PHE.
PHE item Item 1 Item 2 Item 3 Item 4 Item 5
Item 1 – 0.61 0.66 0.71 0.67
Item 2 – 0.54 0.60 0.61
Item 3 – 0.78 0.80
Item 4 – 0.78
Item 5 –
TABLE 7 | Factor loadings from CATPCA—one factor solution.
PHE item One factor solution
Item 1 0.74
Item 2 0.71
Item 3 0.84
Item 4 0.89
Item 5 0.88
All factor loadings had a very high value (>0.7), confirming the unidimensionality of the
scale.
chosen because of the ordinal nature of the items. An initial anal-
ysis was performed without any restriction on the number of
metric factors to be estimated. The initial analysis yielded one
factor with eigenvalue 3.37, which is over Kaiser Criterion of 1,
explaining 67.4% of the total variability. The scree plot confirmed
the one factor structure. Table 7 shows the factor loadings for the
one solution of the CATPCA.
Confirmatory Factorial Analysis
AConfirmatory Factor Analysis (CFA) (Figure 2) was performed
on Group 2 (n = 146, 54% males; 46% females, aged from 21 to
84 years old;M = 51.3 years, SD = 16.6) to study the replicabil-
ity of the factor structure obtained by CATPCA. The estimation
method was asymptotically distribution free, particularly suitable
for ordinal data and not-Gaussian distributions. To evaluate the
closeness of the hypothetical model to the empirical data, mul-
tiple goodness-of-fit indexes were used, including the ratio of
the chi-square to degrees of freedom (χ2/df), the Comparative
Fit Index (CFI), the Standardized Root Mean Square Residual
(SRMR), and the Root Mean Square Error of Approximation
(RMSEA). To test themodel, each variable was allowed to load on
only one factor, and one variable loading in the latent factor was
fixed at 1.0. For the remaining factor loadings, residual variances
were freely estimated.
CFA showed reasonable goodness of fit indices. The fit indices
met the criteria of fit for the hypothesized one-factor structure.
Chi square (χ2 = 10.98, df = 5, p = 0.052) value and goodness
of fit indices (CFI = 0.981, RMR = 0.018, RMSEA = 0.059) sug-
gested that the model is coherent with the data. The analysis of
modification indices did not find the relation between the error
covariance of the items.
To verify the validity and generalizability of the factor struc-
ture, a multigroup confirmatory analysis tested measurement
invariance in the two subsamples divided by gender. Table 8
shows the verified invariance hypothesis. The 1χ2 between the
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FIGURE 2 | CFA on PHE scale: Standardized estimates.
TABLE 8 | Multigroup CFA by gender.
Model χ2 df RMSEA CFI 1χ2(df) p
Unconstrained 10.9 5 0.059 0.971 – –
Invariant factor loading 27.1 15 0.049 0.945 16.2 (10) 0.09
unconstrained and constrained models did not yield significant
results. The factor structure was invariant by gender.
Rasch Model
A Rasch Model was implemented to further investigate whether
the PHE scale was uni-dimensional, and whether all items fit the
model well.
Two (infit and outfit) mean square (MNSQ) statistics were
computed to check whether the items fit the expected model.
MNSQ determines how well each item contributes to defining
a single underlying construct (unidimensionality). Infit is more
sensitive to misfitting responses to items closest to the person’s
ability level while outfit is more sensitive to misfitting items that
are farther away. If the data fitted the Rasch Model, the fit statis-
tics should be between 0.6 and 1.4. According to Wright et al.
(1994), regarding clinical observations, the fit statistics could be
between 0.5 and 1.5.Table 9 shows the results of the Rasch Analy-
sis. The measure of each item represents the estimate for the item
difficulty expressed in logits; SEM is the standard error of mea-
surement in estimation of the item difficulty; Infit and Outfit are
measures of item fit.
Infit and Outfit statistics ranged from 0.62 to 1.14, which all
are within the acceptable range. The person separation index
(PSI) was calculated to evaluate the reliability in the Rasch Model
(PSI= 0.884).
Rasch Model confirmed the unidimensionality of PHE scale
and the fit of each item of the scale to the data.
TABLE 9 | PHE scale—Rasch Analysis.
PHE item Measure (logits) SEM Infit MNSQ Outfit MNSQ
Item 1 1.88 0.11 0.90 0.89
Item 2 0.55 0.10 1.14 1.14
Item 3 0.68 0.10 0.74 0.72
Item 4 1.48 0.10 0.63 0.63
Item 5 0.93 0.10 0.62 0.65
TABLE 10 | Ordinal Alpha via Empirical Copula if item deleted.
Item Ordinal Alpha if item deleted
Item 1 0.82
Item 2 0.82
Item 3 0.78
Item 4 0.77
Item 5 0.77
Internal Consistency and Test-Retest Reliability
Analysis
As in the pilot study, PHE scale had a very good internal consis-
tency, since the value of the Ordinal Alpha via Empirical Copula
was equal to 0.85. In Table 10, the Ordinal Alpha was evaluated
after deleting individual items. Each item contributed signifi-
cantly to the PHE scale score. The internal consistency of the
5-item PHE scale was satisfactory.
Test-Retest reliability was examined by calculating two-way
mixed, absolute concordance intra-class correlation coefficient
(ICC). A sample of 30 participants was retested after 15 days.
This subsample did not differ significantly from the initial sam-
ple in terms of gender [χ2(1) = 0.004, p = 0.94]. According
to Fleiss parameters (1986), ICC yielded excellent results after 15
days (ICC= 0.95; CI= 0.90−0.97).
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Concurrent Validity
To assess concurrent validity, PHE factor scores were evaluated
in relation to PAM and MMAS-4 scores.
First, a Pearson correlation was calculated. The results showed
a moderate correlation between Patient Engagement and Patient
Activation Measures (r = 0.431, p < 0.001). In other words,
higher levels of Engagement were moderately and significantly
related to higher levels of Activation.
For Patient Activation Measures, an independent sam-
ples t-test was conducted to measure the PHE factor scores
for patients with medium or high adherence to medication
(MMAS-4 score =0) and patients with low adherence (MMAS-4
score >0). This classification is considered clinically relevant
(Spatola et al., 2014). Patients with lowMMAS-4 scores, i.e., indi-
cating good adherence to medication, scored significantly higher
on PHE (M = 0.16, SD = 1.01) compared to patients with
low adherence [M = −0.10, SD = 0.99; t(350) = 2.299, p =
0.022]. Furthermore, the correlation between PHE and MMAS-4
scores was significant (r = −0.165, p < 0.01) and negative, in
accordance with theoretical expectations.
Discussion
Although patient engagement has been considered a key fac-
tor to improve healthcare delivery, currently there is a lack of
instruments able to assess patient engagement. To date, only
one instrument, the Patient Activation Measure (PAM), has
been developed by Hibbard et al. (2004, 2005) to measure the
active role of patients in their care. This instrument, although
extremely valuable and widespread in the clinical practice in
several countries (Maindal et al., 2009; Zill et al., 2013; Ahn
et al., 2014; Magnezi and Glasser, 2014), does not appear able
to grasp the complexity and dynamicity of the psychological
experience of patient engagement. Particularly patient activation,
which is the concept underlying the PAM development, mainly
relates to the behavioral and cognitive attitude of a patient in
his/her caremanagement. From previous studies aimed at unveil-
ing the inner subjective experience of engagement of chronic
patients (Barello et al., 2014a, 2015a,b; Graffigna et al., 2014)
we discovered that the emotional elaboration of the disease
diagnosis and of its psycho-social effect on patients’ life, plays
a fundamental role in the development of patients’ engage-
ment. Thus, from our perspective, the path of motivational and
emotional elaboration of the new patient’s identity occurring
after the disease diagnosis (and of the consequent reframing
of daily routines, values, and projects) has to be considered in
order to understand patients’ engagement (Barello and Graffigna,
2014).
Based on the Patient Health Engagement (PHE) model that
we theorized previously, we developed a specific assessment tool
(Graffigna et al., 2013c). Particularly, the PHE scale was struc-
tured based on the systematic analysis of the literature that has
focused on patient engagement and the collection of spontaneous
patient narratives. Particularly, the set of qualitative researches
previously conducted to explore the chronic patients’ engage-
ment journey helped us generate items well attuned to patients’
feelings and to the way in which they express them.
The psychometric analysis of the PHE scale conducted in this
study aimed to (1) evaluate the psychometric properties of the
PHE-scale and (2) evaluate the association between PHE-scale
scores and concurrent measures.
Based on the pilot analysis, 5 items that presented promising
psychometric properties were included in the final version of the
PHE scale. To answer the first objective of the study, three analy-
ses were conducted: (a) an exploratory CATPCA, (b) a confirma-
tory CFA for ordinal data, and (c) a Rasch Model. Furthermore,
we assessed the internal consistency and test-retest reliability of
the scale.
The exploratory categorical principal component analysis
(CATPCA) yielded one factor, which was confirmed in the subse-
quent CFA conducted on an independent sample, thus suggesting
the unidimensionality of the scale and good fit of the model with
the data. Moreover, the Rasch Model confirmed the unidimen-
sionality of PHE scale, and the importance in terms of fitting of
each item of the scale. Finally, a good internal consistency of the
PHE scale was found, as indicated by satisfactory Ordinal Alpha
and the test-retest analysis.
Finally, to assess the concurrent validity of the PHE scale, PHE
factor scores were evaluated in relation to PAM and MMAS-
4 scores. A moderate correlation was found between Patient
Engagement and Patient Activation Measures, thus confirming
our theoretical assumption that patient engagement, although
with some degree of conceptual overlapping, consists in a dif-
ferent and more complex psychological phenomenon compared
to the patient activation. This result seems also be related to
the process-like nature of patient engagement that underlies the
development of the PHE scale, a process that differs from the
mere incremental nature of patient activation.
Moreover, the correlation between PHE and MMAS-4 scores
was significant and negative (which is consistent with theoreti-
cal expectations), although the correlation coefficient was small.
This evidence confirms the theoretical assumption that patient
engagement is related to the adherence of patients in treatment
management, although it shows that the experience of patient
engagement overcomes the singular setting of treatment manage-
ment and relates to a wider kind of relation (“exchange”) between
an individual and the healthcare system during his/her healthcare
journey (Graffigna et al., under review).
The current study is the first to evaluate the psychomet-
rics properties of the PHE scale. Further analyses are needed
to explore the strength of these evidences on other cohorts of
patients and in other countries. However, these findings appear
promising and suggest a high clinical relevance of the instrument.
Particularly, thanks to the bottom up developmental process,
the PHE scale results are able to grasp the complex psycholog-
ical experience of the patient engagement journey, as emerged
from the pilot phase of the study. Furthermore, thanks to its
shortness, the scale can be easily used in the practice of the
clinical encounter in order to train healthcare professional in
patient-centered communication strategies (Lamiani et al., 2012)
aimed at enhancing patients’ engagement in self-management.
Finally, the PHE scale is also featured by methodological inno-
vativeness thanks to its ordinal structure, that results well coher-
ent with the PHE model conceptualization. In addition patients
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indicated that it was particularly easy to answer to the ques-
tions of the scale, which described well the different psycho-
logical positions that the individuals may experience during the
healthcare journey. We further recommend that our scale be val-
idated among other clinical populations and healthcare settings.
Moreover, future studies should research on the relationship
between patient engagement and other patients’ variables—such
as health-related locus of control, coping styles, adherence to
treatments—in order to identify antecedents and outcomes of
patient engagement.
Supplementary Material
The Supplementary Material for this article can be found
online at: http://www.frontiersin.org/journal/10.3389/fpsyg.
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